Consolidated Non-Financial Information Statement

The report describes PharmaMar Group's focus on discovering, developing and commercializing marine-derived oncology medicines, alongside diagnostics and RNA interference research. It records the 28 June 2019 divestment of the Consumer Chemicals businesses as part of the strategic focus on Biopharmaceuticals. The Group reported an average workforce of 487 people and presented consolidated resource-consumption and emissions data for 2019.